NO942032L - Methods for Preparation of Purified Soluble Type B and A Human Platelet-Derived Growth Factor Travel Fragments - Google Patents

Methods for Preparation of Purified Soluble Type B and A Human Platelet-Derived Growth Factor Travel Fragments

Info

Publication number
NO942032L
NO942032L NO942032A NO942032A NO942032L NO 942032 L NO942032 L NO 942032L NO 942032 A NO942032 A NO 942032A NO 942032 A NO942032 A NO 942032A NO 942032 L NO942032 L NO 942032L
Authority
NO
Norway
Prior art keywords
methods
fragments
growth factor
derived growth
travel
Prior art date
Application number
NO942032A
Other languages
Norwegian (no)
Other versions
NO942032D0 (en
Inventor
David Wolf
James E Tomlinson
Original Assignee
Cor Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cor Therapeutics Inc filed Critical Cor Therapeutics Inc
Publication of NO942032D0 publication Critical patent/NO942032D0/en
Publication of NO942032L publication Critical patent/NO942032L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

Cellelinjer og fremgangsmåter for meget effektiv produksjon av oppløselige peptider som har blodplate-avledede vekstfaktor-(PDGF)-ligandbindende aktivitet. Det tilveie- bringes cellelinjer som utsondrer oppløselige fragmenter fra ekstracellulære regioner av PDGF-reseptor-(PDGF-R)- polypeptider. Fremgangsmåter for anvendelse av disse celle- linjer for produksjon av fragmentene er også beskrevet.Cell lines and methods for highly efficient production of soluble peptides having platelet-derived growth factor (PDGF) ligand binding activity. Cell lines are provided which secrete soluble fragments from extracellular regions of PDGF receptor (PDGF-R) polypeptides. Methods for using these cell lines to produce the fragments are also described.

NO942032A 1991-12-02 1994-06-01 Methods for Preparation of Purified Soluble Type B and A Human Platelet-Derived Growth Factor Travel Fragments NO942032L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80179491A 1991-12-02 1991-12-02
PCT/US1992/010430 WO1993011223A1 (en) 1991-12-02 1992-12-01 Methods for production of purified soluble type b and type a human platelet-derived growth factor receptor fragments

Publications (2)

Publication Number Publication Date
NO942032D0 NO942032D0 (en) 1994-06-01
NO942032L true NO942032L (en) 1994-06-01

Family

ID=25182041

Family Applications (1)

Application Number Title Priority Date Filing Date
NO942032A NO942032L (en) 1991-12-02 1994-06-01 Methods for Preparation of Purified Soluble Type B and A Human Platelet-Derived Growth Factor Travel Fragments

Country Status (9)

Country Link
EP (1) EP0619836A4 (en)
JP (1) JPH07501702A (en)
AU (1) AU675924B2 (en)
CA (1) CA2124957A1 (en)
NO (1) NO942032L (en)
NZ (1) NZ246256A (en)
PL (1) PL171788B1 (en)
RU (1) RU94046397A (en)
WO (1) WO1993011223A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5468468A (en) * 1989-02-09 1995-11-21 The United States Of America, As Represented By The Secretary Of The Department Of Health & Human Services Method for making a monoclonal antibody, monoclonal antibodies to α PD
US6228600B1 (en) 1992-07-20 2001-05-08 The United States Of America As Represented By The Department Of Health And Human Services Immunoassays for the alpha platelet-derived growth factor receptor
US7252929B2 (en) 1989-02-09 2007-08-07 United States Of America, As Represented By The Secretary, Dept Of Health & Human Services Methods for identifying alpha PDGFR agonists and antagonists
WO1992013867A1 (en) * 1991-01-31 1992-08-20 Cor Therapeutics, Inc. Domains of extracellular region of human platelet derived growth factor receptor polypeptides
US5817310A (en) * 1991-12-02 1998-10-06 Cor Therapeutics, Inc. Inhibitory immunoglobulin polypeptides to human PDGF beta receptor

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0325224B1 (en) * 1988-01-22 1996-07-31 ZymoGenetics, Inc. Methods of producing secreted receptor analogs
AU607306B2 (en) * 1988-02-02 1991-02-28 Regents Of The University Of California, The Human platelet-derived growth factor receptor
AU2899489A (en) * 1988-02-05 1989-08-10 Guardian Technologies, Inc. Apparatus for delivering a breath sample to a solid state sensor
WO1992013867A1 (en) * 1991-01-31 1992-08-20 Cor Therapeutics, Inc. Domains of extracellular region of human platelet derived growth factor receptor polypeptides
IE920318A1 (en) * 1991-01-31 1992-07-29 Univ California Human platelet-derived growth factor receptors

Also Published As

Publication number Publication date
EP0619836A1 (en) 1994-10-19
JPH07501702A (en) 1995-02-23
NZ246256A (en) 1996-01-26
CA2124957A1 (en) 1993-06-10
EP0619836A4 (en) 1996-12-04
NO942032D0 (en) 1994-06-01
PL171788B1 (en) 1997-06-30
RU94046397A (en) 1996-10-10
AU675924B2 (en) 1997-02-27
AU3236493A (en) 1993-06-28
WO1993011223A1 (en) 1993-06-10

Similar Documents

Publication Publication Date Title
DK1149905T3 (en) Methods and Preparation for Polypeptide Technology
ATE364695T1 (en) SHORTENED SOLUBLE TYPE I RECEPTORS FOR TUMOR NECROSIS FACTOR
NO891388L (en) PROCEDURE FOR THE PREPARATION OF OLEFINES FROM NATURAL GAS.
HUP9802212A2 (en) Recombinant anti-cd4 antibodies for human therapy
DK0778890T3 (en) DNA encoding a human calcium channel alpha-1E subunit
NO852567L (en) THYMOPENTIN ANALOGS AND PROCEDURES FOR THEIR PREPARATION.
ES8503689A1 (en) Teichomycin A2 pure single factors 1, 2, 3, 4 and 5 and method for their production
NO900031D0 (en) PROCEDURE FOR THE PREPARATION OF OLEFINES FROM NATURAL GAS.
SG54339A1 (en) Novel crystal form of anhydrous 7-(1alpha,salpha, 6alpha,]-6-amino-3-azabicyclo [3.1.0]hex-3-yl)-6-fluoro-1-(2,4-difluorophenyl) (pls refer to file for full detail)
IL112557A0 (en) Peptides that are vip antagonists and pharmaceutical compositions comprising them
NO942032L (en) Methods for Preparation of Purified Soluble Type B and A Human Platelet-Derived Growth Factor Travel Fragments
AU3526689A (en) Peptides that block the binding of hiv-1 to the cd4 receptor protein
DE69324601T2 (en) MULTIFUNCTIONAL NEUROTROPHIC FACTORS
ES8203343A1 (en) Amino substituted tetrahydrobenzindoles, a process for preparing and a pharmaceutical composition containing the same.
NO991867L (en) Biaromatic compounds bonded via a heteroethynylene radical, and pharmaceutical and cosmetic compositions containing them
IT8449372A0 (en) ANTI-IDIOTYPE ANTIBODIES INDUCED BY SYNTHETIC POLYPEPTIDES, DIAGNOSTIC SYSTEMS AND VACCINES BASED ON THEM AND PROCEDURE FOR THEIR PREPARATION
DK369885A (en) NON-SUBSTANCING, ANTIBIOTIC, ISSUE ANTICOCCIDIAL FEED PREPARATIONS AND PROCEDURES FOR THEIR PREPARATION
DE306767T1 (en) SYSTEM FOR SEPARATING COMPLEX STRUCTURES.
AU1791497A (en) At1 receptor antagonist for the stimulation of apoptosis
ES8504776A1 (en) Substituted phenylpiperazine compounds suitable as antihypertensive agents, and processes for their production.
DK165184A (en) PYRAZOLOPYRIDINE DERIVATIVES, THERAPEUTIC PREPARATIONS CONTAINING THEM AND PROCEDURES FOR PREPARING THEREOF
DE3682368D1 (en) MITOGENIC PEPTIDES.
AU7129694A (en) Hemoregulatory penta- or hexapeptides
MX9704796A (en) Novel peptides, their production and use.
MX9804706A (en) Fused isoindolones as inhibitors of protein kinase c.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application